IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAH1. A total of 23 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $7,690,782 | +7.4% | 7,000,000 | 0.0% | 0.09% | +9.3% |
| Q3 2022 | $7,164,000 | -4.8% | 7,000,000 | 0.0% | 0.09% | -2.3% |
| Q2 2022 | $7,527,000 | -9.4% | 7,000,000 | 0.0% | 0.09% | -1.1% |
| Q1 2022 | $8,308,000 | +4.3% | 7,000,000 | 0.0% | 0.09% | +4.7% |
| Q4 2021 | $7,965,000 | -5.9% | 7,000,000 | 0.0% | 0.08% | +2.4% |
| Q3 2021 | $8,460,000 | +0.9% | 7,000,000 | 0.0% | 0.08% | -3.5% |
| Q2 2021 | $8,387,000 | +5.7% | 7,000,000 | 0.0% | 0.09% | +10.3% |
| Q1 2021 | $7,938,000 | -51.5% | 7,000,000 | -51.7% | 0.08% | -56.2% |
| Q4 2020 | $16,367,000 | +15.0% | 14,500,000 | 0.0% | 0.18% | -8.2% |
| Q3 2020 | $14,228,000 | – | 14,500,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 69,285,732 | $54,302,494 | 2.70% |
| CAMDEN ASSET MANAGEMENT L P /CA | 50,071,000 | $48,664,005 | 1.81% |
| Boussard & Gavaudan Investment Management LLP | 6,577 | $6,483,091 | 0.76% |
| READYSTATE ASSET MANAGEMENT LP | 12,000,000 | $11,722,800 | 0.59% |
| BRAIDWELL LP | 15,500,000 | $15,141,950 | 0.48% |
| WOLVERINE ASSET MANAGEMENT LLC | 39,174,000 | $38,348,717 | 0.43% |
| CSS LLC/IL | 5,500,000 | $5,379,280 | 0.35% |
| SHENKMAN CAPITAL MANAGEMENT INC | 3,239,000 | $3,239,825 | 0.24% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 15,174,000 | $14,823,481 | 0.07% |
| Calamos Advisors LLC | 9,500,000 | $9,281,500 | 0.05% |